{"id":14736,"date":"2025-02-28T10:43:03","date_gmt":"2025-02-28T15:43:03","guid":{"rendered":"https:\/\/whizkid.com\/a4pc\/?p=14736"},"modified":"2025-03-03T10:44:21","modified_gmt":"2025-03-03T15:44:21","slug":"our-tirzepatide-memo-to-bops","status":"publish","type":"post","link":"https:\/\/whizkid.com\/a4pc\/2025-02\/our-tirzepatide-memo-to-bops\/","title":{"rendered":"Our tirzepatide memo to BoPs"},"content":{"rendered":"<p>The whole legal saga surrounding tirzepatide has meant there\u2019s a lot of confusion, even among state boards of pharmacy. That\u2019s why we wrote <a href=\"https:\/\/join.a4pc.org\/hubfs\/State-level%20Resources\/Memo-Tirzepatide-Shortage-Update_2-17-25.pdf\" data-hs-link-id=\"0\">a simple, 2-page memo<\/a> for those state boards that explains the current legal and regulatory situation around compounding tirzepatide.\u00a0<\/p>\n<p>In short, <strong>FDA has made clear that it will exercise \u201cenforcement discretion\u201d related to tirzepatide compounding<\/strong> (i.e., it won\u2019t take action against either 503A pharmacies or 503B facilities) at least in terms of shortage compounding; it will obviously still take action for other issues, such as quality or safety.<\/p>\n<p>That discretion will last until the US district court rules on the Outsourcing Facilities Association\u2019s motion for a preliminary injunction in its suit against FDA (or until March 19, 2025 for 503B facilities, if that comes later).<\/p>\n<p><strong>If your state BoP isn\u2019t aware of the agency\u2019s decision about enforcement, please <\/strong><strong><a href=\"https:\/\/join.a4pc.org\/hubfs\/State-level%20Resources\/Memo-Tirzepatide-Shortage-Update_2-17-25.pdf\" data-hs-link-id=\"1\">download a copy of our memo<\/a><\/strong><strong> and share it with them.<\/strong> It may help cut through some of the confusion.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>We wrote a simple, 2-page memo for state boards explaining the current legal and regulatory situation around compounding tirzepatide.\u00a0<br \/><span class=\"read-more\"><a target=\"_blank\" href=\"https:\/\/whizkid.com\/a4pc\/2025-02\/our-tirzepatide-memo-to-bops\/\"><\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-14736","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/posts\/14736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/comments?post=14736"}],"version-history":[{"count":1,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/posts\/14736\/revisions"}],"predecessor-version":[{"id":14737,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/posts\/14736\/revisions\/14737"}],"wp:attachment":[{"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/media?parent=14736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/categories?post=14736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/whizkid.com\/a4pc\/wp-json\/wp\/v2\/tags?post=14736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}